Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.

CONCLUSION: The downregulation of DAL-1 and TOB1 expression is associated with shorter survival of gastric cancer patients. Hence, DAL-1 and TOB1 may be considered potential novel markers for predicting the outcomes of patients with gastric cancer. PMID: 30962003 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30962003?dopt=Abstract

Source: Pathology, Research and Practice - April 1, 2019 Category: Pathology Authors: Guo H, Zhang R, Afrifa J, Wang Y, Yu J Tags: Pathol Res Pract Source Type: research